Evaluation of an individualized starting dose of niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study
Year: 2020
Type: conference-paper
Source: Geburtshilfe und Frauenheilkunde
Institutions: Heidelberg University, University Hospital Heidelberg, Rigshospitalet, Nordic Society of Gynecologic Oncology, Clinica Universidad de Navarra, Medical University of South Carolina, The Ohio State University, Hospital Clínic de Barcelona, Hospital Universitario Ramón y Cajal, Cleveland Clinic, Cliniques Universitaires Saint-Luc, UCLouvain, Augusta University, Ghent University Hospital, Minnesota Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Centre Antoine Lacassagne, Klinikum Ludwigshafen, Cancer Trials Ireland, Tel Aviv University, Sheba Medical Center, GlaxoSmithKline (United Kingdom), University of Arizona, The US Oncology Network, Arizona Oncology
Language: German
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3095927104